Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

To the Editor: “Complete Resolution of Multiple Warts after a First Dose of the Receptor Interleukin-5 Inhibitor”

To the Editor: “Complete Resolution of Multiple Warts after a First Dose of the Receptor... Journal of Clinical Immunology (2022) 42:684–687 https://doi.org/10.1007/s10875-021-01202-4 LE T TER TO   EDITOR To the Editor: “Complete Resolution of Multiple Warts after a First Dose of the Receptor Interleukin-5 Inhibitor” 1,2 1,2 3 4 Kissy Guevara‑Hoyer  · Eduardo de la Fuente‑Munoz  · Celia Pinedo Sierra  · Teresa Robledo  · 1,2 Silvia Sánchez‑Ramón Received: 17 October 2021 / Accepted: 13 December 2021 / Published online: 4 January 2022 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 Case Report anti-immunoglobulin E (anti-IgE, omalizumab, 2015–2016), anti-interleukin-5 (anti-IL-5, mepolizumab, 2017–2018). The patient was a 42-year-old man with a long medical his- Despite the treatments, the patient continued to present tory of multiple warts on hands, feet, and genital region (> 5–6 annual severe asthma episodes with the need for anti- 15 active lesions) since childhood associated with human biotics, requiring hospital admission and care in intensive papillomavirus (HPV), followed in our center since 2010 care with respiratory support on three occasions, with the by the Dermatology department. He had received multiple development of respiratory failure requiring home oxygen. treatments, as trichloroacetic acid, topical antiviral chem- Due to the poor clinical evolution and poor response to pre- otherapies (imiquimod), cryotherapy, and laser, without vious treatment, it was considered to start http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Immunology Springer Journals

To the Editor: “Complete Resolution of Multiple Warts after a First Dose of the Receptor Interleukin-5 Inhibitor”

Loading next page...
 
/lp/springer-journals/to-the-editor-complete-resolution-of-multiple-warts-after-a-first-dose-x2q6AclEQL

References (6)

Publisher
Springer Journals
Copyright
Copyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
ISSN
0271-9142
eISSN
1573-2592
DOI
10.1007/s10875-021-01202-4
Publisher site
See Article on Publisher Site

Abstract

Journal of Clinical Immunology (2022) 42:684–687 https://doi.org/10.1007/s10875-021-01202-4 LE T TER TO   EDITOR To the Editor: “Complete Resolution of Multiple Warts after a First Dose of the Receptor Interleukin-5 Inhibitor” 1,2 1,2 3 4 Kissy Guevara‑Hoyer  · Eduardo de la Fuente‑Munoz  · Celia Pinedo Sierra  · Teresa Robledo  · 1,2 Silvia Sánchez‑Ramón Received: 17 October 2021 / Accepted: 13 December 2021 / Published online: 4 January 2022 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 Case Report anti-immunoglobulin E (anti-IgE, omalizumab, 2015–2016), anti-interleukin-5 (anti-IL-5, mepolizumab, 2017–2018). The patient was a 42-year-old man with a long medical his- Despite the treatments, the patient continued to present tory of multiple warts on hands, feet, and genital region (> 5–6 annual severe asthma episodes with the need for anti- 15 active lesions) since childhood associated with human biotics, requiring hospital admission and care in intensive papillomavirus (HPV), followed in our center since 2010 care with respiratory support on three occasions, with the by the Dermatology department. He had received multiple development of respiratory failure requiring home oxygen. treatments, as trichloroacetic acid, topical antiviral chem- Due to the poor clinical evolution and poor response to pre- otherapies (imiquimod), cryotherapy, and laser, without vious treatment, it was considered to start

Journal

Journal of Clinical ImmunologySpringer Journals

Published: Apr 1, 2022

There are no references for this article.